Articles
Start-up seeks to improve stability of antibodies
Solvanix, an Australian start-up commercialising a technology to improve the stability and reduce side effects associated with antibody therapies, launched today with $2m in MCRF funding. [ + ]
Nanolaser biosensor for simple DNA detection
Researchers from Yokohama National University have created a photonic crystal nanolaser biosensor capable of detecting the adsorption of biomolecules based on the laser's wavelength shift. [ + ]
Controlling ripening in grapes
Researchers in Adelaide are working on ways to control ripening in grapes to ameliorate the effects of global warming. [ + ]
Imugene draws up protocol for HER-Vaxx trial
Imugene (ASX:IMU) has drawn up the protocol for a phase Ib/II trial of HER-Vaxx in gastric cancer and appointed a nonclinical CRO to help guide the IND process for the drug. [ + ]
Antibiotic with no resistance discovered
Researchers from Northeastern University have discovered an antibiotic which eliminates pathogens without encountering any detectable resistance - a promising weapon in the war against superbugs such as methicillin-resistant Staphylococcus aureus.
[ + ]Graeme Clark wins Russ Prize for cochlear implant
Professor Graeme Clark and four international scientists have jointly won the biennial US$500,000 Russ Prize for their contributions to the developing the cochlear implant. [ + ]
Sienna secures first deal for SCD-A7
Sienna Cancer Diagnostics has won the first commercial agreement covering the bladder cancer screening technology based on its SCD-A7 antibody. [ + ]
Life science conference season in Lorne
Throughout February the beautiful Victorian coastal town of Lorne will host a series of conferences that will be of interest to all life scientists.
[ + ]Novogen's TRXE-009 kills melanoma in lab trial
Shares in Novogen (ASX:NRT) surged on Tuesday after the company revealed that its TRXE-009 candidate was highly active against a second target - melanoma - during lab studies. [ + ]
OK, as we suspected - men really are idiots
Males are more likely to be admitted to an emergency department after accidential injuries, more likely to be admitted with a sporting injury and more likely to be involved in a fatal road traffic collision. Put simply, men are more likely to be idiots. [ + ]
A pipette tip is a pipette tip, right? Not even close
The pipette is one of the most commonly used handheld instruments in a research laboratory and the model of the pipette is chosen based on your needs for performance, ergonomics and quality. But it doesn't end there - you may have the most advanced pipette on the market but a poor quality tip means that the reproducibility of your results may be at risk. [ + ]
I study dead people
The decomposition of dead bodies is not the most aesthetically pleasing area of science to study, but for Professor Shari Forbes, it is by far the most interesting. [ + ]
AusBiotech reflects on a year of advocacy and achievement
For the biotechnology industry and for AusBiotech, the past year has been another action-packed period in policy terms, as well as the year the Australian biotech industry was ranked fourth in the world. [ + ]
Identification of a pre-cancerous state in the blood
US researchers have uncovered a 'pre-malignant' state in the blood that significantly increases the likelihood that an individual will develop blood cancers such as leukaemia, lymphoma or myelodysplastic syndrome. [ + ]
Cochlear appoints two new directors
Cochlear has announced that seasoned executives Alison Deans and Glen Boreham will take on non-executive director roles starting from next year. [ + ]
